A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: toxicity of a three- versus a four-week schedule.
about
A prospective study of gemcitabine and carboplatin as first-line therapy in advanced non-small cell lung cancer: toxicity of a three- versus a four-week schedule.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A prospective study of gemcita ...... - versus a four-week schedule.
@ast
A prospective study of gemcita ...... - versus a four-week schedule.
@en
A prospective study of gemcita ...... - versus a four-week schedule.
@nl
type
label
A prospective study of gemcita ...... - versus a four-week schedule.
@ast
A prospective study of gemcita ...... - versus a four-week schedule.
@en
A prospective study of gemcita ...... - versus a four-week schedule.
@nl
prefLabel
A prospective study of gemcita ...... - versus a four-week schedule.
@ast
A prospective study of gemcita ...... - versus a four-week schedule.
@en
A prospective study of gemcita ...... - versus a four-week schedule.
@nl
P2093
P356
P1433
P1476
A prospective study of gemcita ...... - versus a four-week schedule.
@en
P2093
P356
10.1053/SONC.2001.23804
P433
3 Suppl 10
P577
2001-06-01T00:00:00Z